Escherichia coli Dihydropyrimidine Dehydrogenase Is a Novel NAD-Dependent Heterotetramer Essential for the Production of 5,6-Dihydrouracil
Authors:
- 15 February 2011
- journal article
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 193 (4) , 989-993
Abstract
The reductive pyrimidine catabolic pathway is absent in Escherichia coli . However, the bacterium contains an enzyme homologous to mammalian dihydropyrimidine dehydrogenase. Here, we show that E. coli dihydropyrimidine dehydrogenase is the first member of a novel NADH-dependent subclass of iron-sulfur flavoenzymes catalyzing the conversion of uracil to 5,6-dihydrouracil in vivo .Keywords
This publication has 30 references indexed in Scilit:
- β-Alanine as a small molecule neurotransmitterNeurochemistry International, 2010
- The Rut Pathway for Pyrimidine Degradation: Novel Chemistry and Toxicity ProblemsJournal of Bacteriology, 2010
- The protein–DNA contacts in RutR·carAB operator complexesNucleic Acids Research, 2010
- A functional analysis of the pyrimidine catabolic pathway in ArabidopsisNew Phytologist, 2009
- The iscS gene deficiency affects the expression of pyrimidine metabolism genesBiochemical and Biophysical Research Communications, 2008
- RutR is the uracil/thymine‐sensing master regulator of a set of genes for synthesis and degradation of pyrimidinesMolecular Microbiology, 2007
- A hidden metabolic pathway exposedProceedings of the National Academy of Sciences, 2006
- Isolation and characterization of an Escherichia coli B mutant strain defective in uracil catabolismCanadian Journal of Microbiology, 1998
- Pyrimidine catabolism in Pseudomonas aeruginosaFEMS Microbiology Letters, 1991
- Pyrimidine catabolism inPseudomonas aeruginosaFEMS Microbiology Letters, 1991